214 related articles for article (PubMed ID: 33521906)
1. Systematic Review of Erythropoietin (EPO) for Neuroprotection in Human Studies.
Hemani S; Lane O; Agarwal S; Yu SP; Woodbury A
Neurochem Res; 2021 Apr; 46(4):732-739. PubMed ID: 33521906
[TBL] [Abstract][Full Text] [Related]
2. Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis.
Wilhelm-Leen ER; Winkelmayer WC
Am J Kidney Dis; 2015 Jul; 66(1):69-74. PubMed ID: 25636816
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system frontiers for the use of erythropoietin.
Olsen NV
Clin Infect Dis; 2003; 37 Suppl 4():S323-30. PubMed ID: 14582001
[TBL] [Abstract][Full Text] [Related]
4. Intranasal erythropoietin therapy in nervous system disorders.
Genc S; Zadeoglulari Z; Oner MG; Genc K; Digicaylioglu M
Expert Opin Drug Deliv; 2011 Jan; 8(1):19-32. PubMed ID: 21143002
[TBL] [Abstract][Full Text] [Related]
5. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin as a novel neuroprotectant.
Genc S; Koroglu TF; Genc K
Restor Neurol Neurosci; 2004; 22(2):105-19. PubMed ID: 15272145
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research.
Sargin D; Friedrichs H; El-Kordi A; Ehrenreich H
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):573-94. PubMed ID: 21619868
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer.
Lambin P; Ramaekers BL; van Mastrigt GA; Van den Ende P; de Jong J; De Ruysscher DK; Pijls-Johannesma M
Cochrane Database Syst Rev; 2009 Jul; (3):CD006158. PubMed ID: 19588382
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin (epoetin) as a protective factor for the brain.
Malhotra S; Nijhawan S; Rosenbaum DM
Curr Atheroscler Rep; 2004 Jul; 6(4):301-6. PubMed ID: 15191705
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin in Optic Neuropathies: Current Future Strategies for Optic Nerve Protection and Repair.
Lai YF; Lin TY; Ho PK; Chen YH; Huang YC; Lu DW
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806148
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective properties of epoetin alfa.
Cerami A; Brines M; Ghezzi P; Cerami C; Itri LM
Nephrol Dial Transplant; 2002; 17 Suppl 1():8-12. PubMed ID: 11812906
[TBL] [Abstract][Full Text] [Related]
12. Effects of epoetin alfa on the central nervous system.
Cerami A; Brines ML; Ghezzi P; Cerami CJ
Semin Oncol; 2001 Apr; 28(2 Suppl 8):66-70. PubMed ID: 11395856
[TBL] [Abstract][Full Text] [Related]
13. Treating patients with schizophrenia deficit with erythropoietin?
Fond G; Macgregor A; Attal J; Larue A; Brittner M; Ducasse D; Capdevielle D
Psychiatry Clin Neurosci; 2012 Aug; 66(5):375-82. PubMed ID: 22725970
[TBL] [Abstract][Full Text] [Related]
14. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
[TBL] [Abstract][Full Text] [Related]
15. The non-haematopoietic biological effects of erythropoietin.
Arcasoy MO
Br J Haematol; 2008 Apr; 141(1):14-31. PubMed ID: 18324962
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective role of erythropoietin in neonates.
Juul S
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():105-7. PubMed ID: 22958035
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin in Glaucoma: From Mechanism to Therapy.
Lai YF; Lin TY; Chen YH; Lu DW
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769310
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of erythropoietin in treating experimental traumatic brain injury: a systematic review of controlled trials in animal models.
Peng W; Xing Z; Yang J; Wang Y; Wang W; Huang W
J Neurosurg; 2014 Sep; 121(3):653-64. PubMed ID: 25036201
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection of erythropoietin and methylprednisolone against spinal cord ischemia-reperfusion injury.
Xiong M; Chen S; Yu H; Liu Z; Zeng Y; Li F
J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):652. PubMed ID: 22038355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
